Trials / Completed
CompletedNCT03993119
This Study Observes the Usage of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) in Elderly Patients With a Heart Rhythm Disorder in Spain
Non-Interventional, Cross-sectional Study to Describe NOACs Management in Elderly Patients With Non-valvular Atrial Fibrillation (NVAF) in Spain.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 75 Years
- Healthy volunteers
- Not accepted
Summary
This is an observational, multicenter and cross-sectional study in Non-valvular atrial fibrillation (NVAF) elderly patients currently on Non-vitamin K antagonist oral anticoagulant (NOAC) treatment for their stroke prevention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Non-vitamin K antagonist oral anticoagulant | Non-vitamin K antagonist oral anticoagulant |
Timeline
- Start date
- 2019-07-30
- Primary completion
- 2020-08-20
- Completion
- 2020-08-20
- First posted
- 2019-06-20
- Last updated
- 2021-09-29
- Results posted
- 2021-09-02
Locations
45 sites across 1 country: Spain
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03993119. Inclusion in this directory is not an endorsement.